Baxter International (NYSE:BAX) updated its third quarter earnings guidance on Thursday. The company provided earnings per share guidance of $0.82-0.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.86. The company issued revenue guidance of $2.85-2.88 billion, compared to the consensus revenue estimate of $2.84 billion.Baxter International also updated its FY19 guidance to $3.34-3.40 EPS.

A number of analysts have recently issued reports on the stock. BMO Capital Markets cut their price target on shares of World Acceptance to $65.00 and set an underperform rating for the company in a report on Friday. Piper Jaffray Companies raised their price target on shares of Baxter International from $90.00 to $95.00 and gave the stock an overweight rating in a report on Thursday. Wells Fargo & Co upgraded shares of Centurylink from a market perform rating to an outperform rating and raised their price target for the stock from $12.00 to $14.00 in a report on Wednesday, June 26th. Raymond James raised their price target on shares of Republic Services from $83.00 to $93.00 and gave the stock an outperform rating in a report on Friday. Finally, Cowen set a $75.00 price target on shares of Baxter International and gave the stock a hold rating in a report on Monday, April 22nd. Four research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The stock presently has an average rating of Buy and a consensus price target of $83.40.

BAX stock traded down $0.01 during midday trading on Friday, hitting $85.15. The company’s stock had a trading volume of 2,545,105 shares, compared to its average volume of 2,248,267. The company has a quick ratio of 1.30, a current ratio of 1.83 and a debt-to-equity ratio of 0.50. Baxter International has a 52-week low of $61.05 and a 52-week high of $86.65. The company has a market cap of $43.44 billion, a price-to-earnings ratio of 27.92, a P/E/G ratio of 1.99 and a beta of 0.99. The firm has a 50-day moving average of $81.27.

Baxter International (NYSE:BAX) last released its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.89 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.08. The business had revenue of $2.84 billion during the quarter, compared to analysts’ expectations of $2.80 billion. Baxter International had a net margin of 14.28% and a return on equity of 20.98%. The company’s revenue for the quarter was down .1% on a year-over-year basis. During the same period in the previous year, the company earned $0.77 EPS. On average, research analysts expect that Baxter International will post 3.38 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, August 30th will be paid a dividend of $0.22 per share. The ex-dividend date is Thursday, August 29th. This represents a $0.88 annualized dividend and a yield of 1.03%. Baxter International’s dividend payout ratio is currently 28.85%.

In related news, SVP Jacqueline Kunzler sold 593 shares of Baxter International stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $80.46, for a total transaction of $47,712.78. Following the sale, the senior vice president now directly owns 9,023 shares in the company, valued at approximately $725,990.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Thomas T. Stallkamp sold 1,000 shares of Baxter International stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $76.20, for a total transaction of $76,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 5,002,913 shares of company stock worth $382,077,150 over the last quarter. 0.70% of the stock is owned by company insiders.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

See Also: What does a bar chart mean for investors?

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with's FREE daily email newsletter.